Vitro Biopharma, Inc., USA
Vitro Biopharma concentrates on the development of cell therapies derived from Wharton’s jelly. Its research activities are directed toward therapeutic applications in autoimmune and inflammatory disease indications.
Vitro Biopharma concentrates on the development of cell therapies derived from Wharton’s jelly. Its research activities are directed toward therapeutic applications in autoimmune and inflammatory disease indications.